ISOLATION, PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF HUMAN PLACENTAL INTERFERONS BY TANDEM HIGH-PERFORMANCE AFFINITY-CHROMATOGRAPHY

被引:9
作者
ABOAGYEMATHIESEN, G
TOTH, FD
DALSGAARD, AM
PETERSEN, PM
ZACHAR, V
EBBESEN, P
机构
[1] DEBRECEN UNIV MED,INST MICROBIOL,H-4012 DEBRECEN,HUNGARY
[2] SLOVAK ACAD SCI,INST VIROL,CS-80936 BRATISLAVA,CZECHOSLOVAKIA
来源
PREPARATIVE BIOCHEMISTRY | 1992年 / 22卷 / 02期
关键词
D O I
10.1080/10826069208021362
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human placental trophoblasts, fibroblasts and the trophoblast-derived malignant cell JAR are potent producers of interferons (IFNs) when stimulated with Sendai virus. The three cell lines produced different levels and compositions of IFN-alpha-subtypes and IFN-beta. Anti-IFN globulins, Cibacron Blue F3GA and Concanavalin A were covalently immobilized on pressure-stable, macroporous polymeric matrices derivatized with vinyl sulphone (HEMA-BIO 1000 VS and HEMA 1000 VS). These supports were packed in biocompatible PEEK columns and were coupled with switching valves, to develop a tandem high-performance affinity chromatographic (HPAC) method for the isoiation, purification and biochemical characterization of the IFNs produced in Sendai virus-stimulated human placental trophoblasts, fibroblasts and trophoblast-derived malignant cell, JAR, cultures. Silver-stained SDS-PAGE and gel densitometric analysis revealed the purity of the purified proteins to be between 94 and 98%. Specific activities of the purified IFNs ranged between 0.37 - 2.76 x 10(8) IU/mg of protein with commulative recoveries between 90 and 92.2%. The purified IFN components exhibited quantitatively different antiviral activities in human and bovine cell lines. The utility of the tandem method for the purification and characterization of human type 1 IFNs produced from other cell lines are also discussed.
引用
收藏
页码:105 / 121
页数:17
相关论文
共 21 条
[1]   PURIFICATION OF HUMAN PLACENTAL TROPHOBLAST INTERFERON BY 2-DIMENSIONAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ABOAGYEMATHIESEN, G ;
TOTH, FD ;
JUHL, C ;
NORSKOVLAURITSEN, N ;
PETERSEN, PM ;
EBBESEN, P .
PREPARATIVE BIOCHEMISTRY, 1991, 21 (01) :35-51
[2]   INTERFERON RESPONSE TO SENDAI AND RUBELLA VIRUSES IN HUMAN FOETAL CULTURES, LEUCOCYTES AND PLACENTAL CULTURES [J].
BANATVALA, JE ;
POTTER, JE ;
BEST, JM .
JOURNAL OF GENERAL VIROLOGY, 1971, 13 (NOV) :193-+
[3]  
BAZER FW, 1986, J REPROD FERTIL, V76, P841, DOI 10.1530/jrf.0.0760841
[4]  
BOCCI V, 1985, P SOC EXP BIOL MED, V180, P137
[5]   CONFORMATION AND ACTIVITY OF RECOMBINANT HUMAN FIBROBLAST INTERFERON-BETA [J].
BOUBLIK, M ;
MOSCHERA, JA ;
WEI, C ;
KUNG, HF .
JOURNAL OF INTERFERON RESEARCH, 1990, 10 (02) :213-219
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   RELATIONSHIP BETWEEN PHYSICOCHEMICAL NATURE OF HUMAN INTERFERON, CELL INDUCED, AND INDUCING AGENT [J].
CESARIO, TC ;
SCHRYER, PJ ;
TILLES, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) :291-298
[8]   ALPHA-INTERFERON IN HUMAN-PREGNANCY [J].
CHARD, T ;
CRAIG, PH ;
MENABAWEY, M ;
LEE, C .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1986, 93 (11) :1145-1149
[9]   CLONING AND EXPRESSION OF CDNA-ENCODING OVINE TROPHOBLASTIN - ITS IDENTITY WITH A CLASS-II ALPHA-INTERFERON [J].
CHARLIER, M ;
HUE, D ;
MARTAL, J ;
GAYE, P .
GENE, 1989, 77 (02) :341-348
[10]  
DERMAEYER E, 1988, INTERFERONS OTHER RE